Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Philippe Dutheil

Investment Director

Mailys Ferrere

Director of Large Venture Investments

Jean-Marie Fougeray

Senior Investment Director, Brittany

Paul-Francois Fournier

Executive Director, Innovation Department

Pierre Gillet

Investment Director

Vanessa Giraud

Managing Director

Gwenaël Hamon

Senior Investment Director

Laurent Higueret Ph.D

Senior Investment Director

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Chahra Louafi

Senior Investment Director

Elyssa Maufras du Châtellier

Investment Director

Quentin Mayolle

Senior Investment Officer

Serge Mesguich

Director of FIT

Laure Michel

Investment Director

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Néel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Director

Claire Waché

Senior Investment Officer

Past deals in Personal Health

H'ability

Seed Round in 2025
H'ability specializes in providing immersive virtual reality (VR) therapeutic exercises that complement traditional rehabilitation methods. The company offers a wireless VR headset with customizable exercises targeting motor skills, balance, and cognitive functions. Their platform features real-time session personalization, detailed progress tracking with data analytics, and compatibility with additional rehabilitation tools. This enables healthcare professionals to deliver personalized, engaging, and efficient therapy sessions in clinical settings or at patients' homes, catering to various medical conditions.

Fizimed

Venture Round in 2025
Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.

Doado

Seed Round in 2024
Doado is a health technology company that specializes in developing mobile applications for back health management. Its primary product is an e-health application designed to guide users step by step in improving their back health and preventing Musculoskeletal Disorders. The application offers personalized video programs, expert advice from physiotherapists and doctors, and AI-driven progress tracking, enabling individuals and companies to maintain an active lifestyle and reduce the risk of chronic back pain.

Metyos

Pre Seed Round in 2024
Metyos develops wearable biosensor technology to monitor how daily activities affect nutrition, metabolism, and overall health. The device tracks data such as fat levels and energy metabolism dynamics to provide personalized fitness and nutrition guidance, helping users align their routines with weight goals and health outcomes. Based in Paris, France, Metyos translates body responses into actionable insights to support long-term wellness and the prevention of serious health events. The approach relies on day-to-day data to enable individuals to understand how meals, activity, and rest influence metabolic processes, supporting proactive health management and sustainable lifestyle changes. By offering feedback on how actions impact metabolism, Metyos aims to help users regain control of their health and maintain healthier trajectories.

Callyope

Seed Round in 2023
Callyope is a technology company focused on enhancing brain health monitoring through human-centered solutions. By developing a speech-based platform that utilizes natural language processing and signal processing techniques, Callyope enables caregivers to monitor patients' brain functionality more effectively. The platform allows for a detailed examination of patients' verbal productions, providing valuable insights that help identify relapses and inform treatment decisions. Ultimately, Callyope aims to improve the quality of life for patients while also contributing to a reduction in re-hospitalization rates.

Teale

Series A in 2023
Teale is a prominent digital mental health platform that integrates psychology and technology to facilitate mental health care for individuals and organizations. The company offers personalized and engaging digital healthcare solutions, emphasizing the importance of subconscious well-being. Teale's approach includes individual support and collective workshops tailored to the specific needs of users, thereby enhancing the effectiveness of mental health initiatives. Through its curated network of mental health experts, Teale enables employees to assess their mental health status and access customized digital programs designed to promote their psychological resilience.

Numa Health

Seed Round in 2023
Numa Health is a medical bioinformatics health technology company that focuses on empowering individuals to optimize their health capital and well-being. It has developed a digital health platform that offers tools designed to enhance users' commitment to their health. This platform facilitates the reinterpretation of blood test results, providing insights into bodily functions and overall health. By enabling users to measure, understand, and take actionable steps regarding their health, Numa Health aims to support individuals in their journey towards better health management.

Maddie

Venture Round in 2023
Maddie provides patient and practice management software for physiotherapists and other health professionals. It operates a healthcare platform that helps practitioners manage their practices by offering digital diaries, online appointment bookings, and a customizable and well-referenced website, enabling users to structure waiting lists, optimize schedules, and efficiently handle incoming requests.

Microphyt

Series B in 2022
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Lola Health

Pre Seed Round in 2022
Lola Health is an insurance technology company that specializes in providing personalized complementary health insurance solutions. The firm focuses on enhancing traditional insurance offerings by including support for specific care pathways such as endometriosis, parenthood, postpartum depression, psychology, and alternative medicine. Lola Health's services are designed to assist businesses in retaining employees, attracting new talent, and improving overall performance. Key offerings include Angel Plus, an advisory platform that helps employees find solutions, telecommunications services, and psychological support. The company aims to make insurance more accessible and reduce risk by providing numerous assistance and prevention services.

Cuure

Series A in 2022
Cuure is a company specializing in personalized vitamins and supplements designed to meet individual health needs. Through a combination of health questionnaires and DNA analysis, Cuure creates customized supplement plans aimed at optimizing overall wellness. The company's platform offers tailored recommendations based on scientific research, ensuring that users receive the appropriate dosages of vitamins, minerals, and plant-based ingredients suited to their specific health goals and body chemistry. Additionally, Cuure incorporates a tracking application to help individuals foster wellness habits, making it easier for them to integrate these personalized solutions into their daily routines.

Susu

Debt Financing in 2022
Susu delivers comprehensive health services to families in the African diaspora, spanning preventive care, medical treatments, chronic disease management, and access to authentic medications. Through a bundled, long-term care offering, Susu enables planned health support, regular monitoring of conditions such as pregnancy and chronic diseases, and connects users to quality healthcare services and insurance options, with a focus on affordability and accessibility.

Susu

Grant in 2022
Susu delivers comprehensive health services to families in the African diaspora, spanning preventive care, medical treatments, chronic disease management, and access to authentic medications. Through a bundled, long-term care offering, Susu enables planned health support, regular monitoring of conditions such as pregnancy and chronic diseases, and connects users to quality healthcare services and insurance options, with a focus on affordability and accessibility.

WhatMatters

Seed Round in 2022
WhatMatters offers cosmetics geared for home and hygiene care. They sell items including toothpaste, shower gel, hand sanitizer, cleansing water, dish soap, laundry detergent, and more. They provide a range of products for children as well.

Heroic sante

Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Omini

Seed Round in 2021
Omini develops a portable, multiplex biosensor platform for blood testing that enables the simultaneous detection of multiple biomarkers. The device is designed for chronic disease monitoring and therapy management, providing personalized biomarker data to adjust treatments and help prevent acute crises, with applications for general practitioners. Incorporated in 2019 and based in Saint-Mandé, France, Omini aims to offer a low-cost, regular monitoring solution that supports routine assessment of complex conditions such as heart failure.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Kwit

Series A in 2021
Kwit develops a mobile application that supports smoking cessation by applying evidence-based methods and cognitive-behavioral therapy principles. The app provides daily guidance and encouragement focused on positivity and kindness to help users quit smoking and pursue a healthier, smoke-free life.

Lucine

Seed Round in 2020
Lucine is a company focused on improving patient health, primarily targeting pain management. It develops a mobile health application that offers a digital therapeutic solution designed to relieve pain within five minutes through analgesic neurostimulation. The application employs advanced algorithms to measure and analyze pain by utilizing facial, vocal, and postural recognition. This technology allows for personalized treatment, as it instantly adapts to each patient's specific needs. The application provides a variety of techniques to alleviate pain symptoms, including exercises, relaxation methods, art therapy, and meditation, empowering patients with chronic pain to manage their conditions effectively from home.

Medaviz

Series A in 2020
Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that connects patients with healthcare professionals for immediate medical advice. The platform allows users to contact general practitioners, pediatricians, gynecologists, and psychologists at any time, facilitating access to necessary assistance for various medical issues and emergencies. By enabling direct communication between patients and doctors, Medaviz aims to streamline the process of obtaining medical guidance and support.

Withings

Series B in 2020
Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.

Exeliom

Grant in 2019
Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

Microphyt

Venture Round in 2019
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Fizimed

Seed Round in 2018
Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.

Nomadeec

Venture Round in 2017
Nomadeec is a French mobile telemedicine platform specializing in remote medical decision-making for emergency and scheduled care. It caters to various healthcare professionals such as emergency doctors, sports doctors, paramedics, and others who require urgent intervention or teleconsultations.

Withings

Series B in 2013
Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.